Beware of buzzwords when investing in a new technology, says Derek Lowe at In the Pipeline. He makes fun of an announcement released earlier this year by Primegen, saying that they used carbon nanotubes to reprogram stem cells. Though both are hot fields, they're also still very new. "So what are the odds of getting them to work together? Not as good as the odds that someone thought the combination would make a good press release, I'm afraid," he says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.